Comments on the article “Changes in hypertensive control 2020-2021 in a family medicine unit”

Authors

  • Joaquín Ahumada-Pérez <p>Instituto Mexicano del Seguro Social, Centro M&eacute;dico Nacional Siglo XXI, Hospital de Cardiolog&iacute;a, Servicio de Gabinetes. Ciudad de M&eacute;xico, M&eacute;xico</p> http://orcid.org/0000-0002-4484-2301

DOI:

https://doi.org/10.5281/zenodo.14199999

Keywords:

High Blood Pressure, Antihypertensive Agent, COVID-19 Pandemic, Risk Factors, Primary Health Care

Abstract

The objective of this letter to the editor is to emphasize about the control of chronic diseases, especially hypertension during the COVID-19 pandemic, as well as to comment some aspects about the research done in a primary care unit, specifically about the factors that could contribute on the poor hypertensive control, some of them commented on the article but others not completely clarified.

Downloads

Download data is not yet available.

Author Biography

  • Joaquín Ahumada-Pérez, <p>Instituto Mexicano del Seguro Social, Centro M&eacute;dico Nacional Siglo XXI, Hospital de Cardiolog&iacute;a, Servicio de Gabinetes. Ciudad de M&eacute;xico, M&eacute;xico</p>

    MÉDICO ADSCRITO AL SERVICIO DE GABINETES DEL HOSPITAL DE CARDIOLOGÍA CENTRO MÉDICO NACIONAL SIGLO XXI 

References

Tetetla-Castro D, Cruz-Martín GJ, Castro-Ríos A. Cambios en el control hipertensivo 2020-2021 en una unidad de medicina familiar. Rev Med Inst Mex Seguro Soc. 2024;62(4):e6053. doi: 10.5281/zenodo.11397116.

Jamison DA Jr, Anand Narayanan S, Trovão NS, et al. A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection. Eur J Hum Genet. 2022;30(8):889-98. doi: 10.1038/s41431-022-01108-8

Hacker KA, Briss PA, Richardson L, et al. COVID-19 and Chronic Disease: The Impact Now and in the Future. Prev Chronic Dis. 2021;18:210086. doi: 10.5888/pcd18.210086

Gaya PV, Fonseca GWP, Tanji LT, et al. Smoking cessation decreases arterial blood pressure in hypertensive smokers: A subgroup analysis of the randomized controlled trial GENTSMOKING. Tob Induc Dis. 2024;22. doi: 10.18332/tid/186853

Narayanan SA, Jamison DA Jr, Guarnieri JW, et al. A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection. Eur J Hum Genet. 2024 Jan;32(1):10-20. doi: 10.1038/s41431-023-01462-1

Stachteas P, Symvoulakis M, Tsapas A, et al. The impact of the COVID-19 pandemic on the management of patients with chronic diseases in Primary Health Care. Population Medicine. 2022;4:23. doi: 10.18332/popmed/152606

Downloads

Published

2024-12-17 — Updated on 2025-06-16

Issue

Vol. 63 No. 1 (2025): January-February

Section

Letter to the Editor

License

Copyright (c) 2025 Revista Médica del Instituto Mexicano del Seguro Social

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.